Bristol Myers Squibb announced it will build a $2.3 billion drug manufacturing campus in Houston, Texas, as part of its broader $40 billion five-year U.S. investment commitment. The roughly 600,000-square-foot facility at Generation Park will produce small molecules, biologics, and antibody-drug conjugates, with a design allowing its production footprint to adapt to the company's pipeline. The campus is expected to employ nearly 500 people and support about 2,000 construction workers through 2030. Texas Governor Greg Abbott said the project is eligible for a $4.89 million Texas Enterprise Fund grant and meets criteria for state incentives under the Jobs, Energy, Technology and Innovation program. Bristol Myers raised its full-year revenue guidance to approximately $49 billion to $50 billion, driven by drugs including Eliquis, Camzyos, and Reblozyl.
Bristol-Myers Squibb CompanyBristol Myers announced a $2.3 billion manufacturing campus and raised full-year revenue guidance, indicating strong financial commitment and improved outlook.
